Open angle glaucoma (OAG), one of the leading causes of blindness, affects about 45 million individuals worldwide - about three million in the US - with that number projected to increase to 53 million by 2020. It is most commonly treated using prostaglandin analogue drops, which can lower the increased pressure in the eye,
